Biochips Market Size, Share & Trends Analysis Report By Type (DNA Chips, Lab-on-chip, Cell Arrays), By End-use (Academic & Research Institutes, Hospitals & Diagnostics Centers), And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Biochips Market Growth & Trends
The global biochips market size is expected to reach USD 25.92 billion by 2030, registering a CAGR of 13.35% during the forecast period, according to a new report by Grand View Research, Inc. The rising requirement for drug discovery and development coupled with the adoption of personalized medicine is likely to favor the industry's growth. Furthermore, the rise in the implementation of next-generation sequencing by biotechnology companies around the globe is pushing product demand. For instance, in December 2021, Abbott received CE Mark for the i-STAT TBI Plasma test, a portable analyzer for Traumatic Brain Injury (TBI) blood. Hence, the company is permitted to expand its footprint in the European Union. The innovation in sequencing techniques has allowed researchers to decode DNA molecules up to the level of the complete human genome.
Ion Torrent chip by Thermo Fisher Scientific is one of the technologies based on sequencing by the technique of synthesis. The chip is an advancement in the Next-Generation Sequencing (NGS) technology that makes massively parallel sequencing cost-effective for every lab. Hence, the development of biochips to enhance the NGS application is anticipated to support the growth of the industry. Similarly, increasing government-based initiatives to promote the domestic production of biochips is likely to support the growth in the coming years. This strategic initiative is to match the local demand for the product with the supply. For instance, in July 2022, SiPhox, Inc. received a grant worth USD 681,631 from the Baker-Polito Administration.
The financial support is to accelerate the development of a manufacturing facility for the mass production of pluggable photonic biochips. It is estimated to accelerate the output to around 5,000 biochips per month from around 100 per month to match the rising demand from biotech segments including drug discovery, vaccine development, and distributed diagnostics. Such investments are likely to supplement the industry growth in the coming years. The COVID-19 pandemic is estimated to have a positive impact on industry growth during the forecasted period. Various companies collaborated to develop innovative solutions to deal with the pandemic. For instance, in March 2020, SkyWater Technology announced the collaboration with MGI, to supply essential components for COVID-19 sequencing, including microfluidic MEMS devices.
The growing requirement for personalized medicine is likely to become a key application area for the industry in the coming years. Since biochip is emerging as an important component in molecular diagnostics, their use in point-of-care diagnostics is anticipated to smooth the development of personalized medicines. In addition, gene expression profiling through microarrays is expected to enhance the progress of personalized treatment for cancer based on molecular classification. However, the cost involved in the manufacturing of biochips is considerably high, resulting in high pricing for end-users. For instance, Josep Carreras Leukaemia Research Institute (IJC) provides microarray to researchers. The cost of GeneChip Human Gene 2.0 ST for whole-transcript expression analysis & profiling ranges from USD 456 to 593 for fresh samples.
Biochips Market Report Highlights
Biochips Market Growth & Trends
The global biochips market size is expected to reach USD 25.92 billion by 2030, registering a CAGR of 13.35% during the forecast period, according to a new report by Grand View Research, Inc. The rising requirement for drug discovery and development coupled with the adoption of personalized medicine is likely to favor the industry's growth. Furthermore, the rise in the implementation of next-generation sequencing by biotechnology companies around the globe is pushing product demand. For instance, in December 2021, Abbott received CE Mark for the i-STAT TBI Plasma test, a portable analyzer for Traumatic Brain Injury (TBI) blood. Hence, the company is permitted to expand its footprint in the European Union. The innovation in sequencing techniques has allowed researchers to decode DNA molecules up to the level of the complete human genome.
Ion Torrent chip by Thermo Fisher Scientific is one of the technologies based on sequencing by the technique of synthesis. The chip is an advancement in the Next-Generation Sequencing (NGS) technology that makes massively parallel sequencing cost-effective for every lab. Hence, the development of biochips to enhance the NGS application is anticipated to support the growth of the industry. Similarly, increasing government-based initiatives to promote the domestic production of biochips is likely to support the growth in the coming years. This strategic initiative is to match the local demand for the product with the supply. For instance, in July 2022, SiPhox, Inc. received a grant worth USD 681,631 from the Baker-Polito Administration.
The financial support is to accelerate the development of a manufacturing facility for the mass production of pluggable photonic biochips. It is estimated to accelerate the output to around 5,000 biochips per month from around 100 per month to match the rising demand from biotech segments including drug discovery, vaccine development, and distributed diagnostics. Such investments are likely to supplement the industry growth in the coming years. The COVID-19 pandemic is estimated to have a positive impact on industry growth during the forecasted period. Various companies collaborated to develop innovative solutions to deal with the pandemic. For instance, in March 2020, SkyWater Technology announced the collaboration with MGI, to supply essential components for COVID-19 sequencing, including microfluidic MEMS devices.
The growing requirement for personalized medicine is likely to become a key application area for the industry in the coming years. Since biochip is emerging as an important component in molecular diagnostics, their use in point-of-care diagnostics is anticipated to smooth the development of personalized medicines. In addition, gene expression profiling through microarrays is expected to enhance the progress of personalized treatment for cancer based on molecular classification. However, the cost involved in the manufacturing of biochips is considerably high, resulting in high pricing for end-users. For instance, Josep Carreras Leukaemia Research Institute (IJC) provides microarray to researchers. The cost of GeneChip Human Gene 2.0 ST for whole-transcript expression analysis & profiling ranges from USD 456 to 593 for fresh samples.
Biochips Market Report Highlights
- The DNA chips type segment accounted for the largest revenue share in 2021 due to the high demand for rapid and accurate detection of cancer
- The drug discovery application segment for lab-on-chip is anticipated to grow at a faster rate during the forecast period as the biochip helps lower the overall cost of drug discovery & development
- The biotechnology and pharmaceutical companies end-user segment captured a significant revenue share in 2021 due to the need for personalized medicines along with the increasing drug discovery & development
- North America held the largest revenue share in 2021 owing to high R&D investment coupled with the accessibility of capital through venture capitalists for startups and the application development of biochips in the region
- Asia Pacific is projected to register the fastest CAGR from 2022 to 2030 owing to various initiatives by local governments to promote domestic product manufacturing
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List of Abbreviations
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 BIOCHIP INDUSTRY OUTLOOK
3.1 Market Segmentation
3.2 Market Size and Growth Prospects, 2021
3.3 Biochip Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increase in adoption of next-generation sequencing
3.3.1.2 Growing R&D in proteomics and genomics
3.3.1.3 Presence of an extensive drug-development pipeline
3.3.1.4 Increasing adoption of personalized medicine
3.3.1.5 Rapid technological advances in biochip technology
3.3.2 Market Restraint Analysis
3.3.2.1 High Cost Of Manufacturing
3.4 Key Opportunities Prioritized, 2021
3.5 Covid-19 Impact Analysis
3.6 Industry Analysis - Porter’s
3.7 Biochip Pestel Analysis
CHAPTER 4 BIOCHIP MARKET - SEGMENT ANALYSIS, BY TYPES, 2018 - 2030 (USD MILLION)
4.1 Global Biochip Market: Type Movement Analysis
4.2 DND Chips, By Application
4.2.1 DND Chips Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.2 Cancer Diagnosis And Treatment
4.2.2.1 Cancer Diagnosis And Treatment Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.3 Gene Expression
4.2.3.1 Gene Expression Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.4 Single Nucleotide Polymorphism (SNP) Genotyping
4.2.4.1 SNP Genotyping Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.5 Genomics
4.2.5.1 Genomics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.6 Drug Discovery
4.2.6.1 Drug Discovery Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.7 Agricultural Biotechnology
4.2.7.1 Agricultural Biotechnology Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.8 Others
4.2.8.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3 Lab-On-A-Chip, By Application
4.3.1 Lab-On-A-Chip Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.2 Clinical Diagnostics
4.3.2.1 Clinical Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.3 Genomics
4.3.3.1 Genomics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.4 In Vitro Diagnosis (IVD) & Point-Of-Care (POC)
4.3.4.1 IVD & POC Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.5 Proteomics
4.3.5.1 Proteomics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.6 Drug Discovery
4.3.6.1 Drug Discovery Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.7 Others
4.3.7.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4 Protein Chips, by Application
4.4.1 Protein Chips Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.2 Proteomics
4.4.2.1 Proteomics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.3 Expression Profiling
4.4.3.1 Expression Profiling Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.4 Diagnostics
4.4.4.1 Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.5 High Throughput Screening (HTS)
4.4.5.1 HTS Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.6 Drug Discovery
4.4.6.1 Drug Discovery Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.7 Others
4.4.7.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.5 Tissue Arrays
4.5.1 Tissue Arrays Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.6 Cell Arrays
4.6.1 Cell Arrays Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 5 BIOCHIP MARKET - SEGMENT ANALYSIS, BY END-USE, 2018 - 2030 (USD MILLION)
5.1 Global Biochip Market: End-Use Movement Analysis
5.2 Biotechnology And Pharmaceutical Companies
5.2.1 Biotechnology And Pharmaceutical Companies Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Hospitals And Diagnostics Centers
5.3.1 Hospitals And Diagnostics Centers Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Academic & Research Institutes
5.4.1 Academic & Research Institutes Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Others
5.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 BIOCHIP MARKET: - SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
6.1 Biochip Market: Regional Movement Analysis
6.2 North America
6.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.4 Spain
6.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.5 France
6.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.6 Italy
6.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2 Japan
6.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.3 China
6.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.4 India
6.4.4.1 India Market Estimates And Forecast, 2018 - 2030
6.4.5 South Korea
6.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030
6.4.6 Australia
6.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030
6.5 Latin America
6.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6 Middle East & Africa (MEA)
6.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6.1 South Africa
6.6.1.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6.2 Saudi Arabia
6.6.2.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6.3 UAE
6.6.3.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Public Companies
7.1.1 Company Market Position Analysis
7.1.2 Competitive Dashboard Analysis
7.1.3 Strategic Framework
7.2 Private Companies
7.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
7.2.2 Regional Network Map
7.3 Company Profiles
7.3.1 ABBOTT LABORATORIES
7.3.1.1 Company Overview
7.3.1.2 Alere, Inc.
7.3.1.3 Financial Performance
7.3.1.4 Product Benchmarking
7.3.1.5 Strategic Initiatives
7.3.2 AGILENT TECHNOLOGIES, INC.
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic Initiatives
7.3.3 PERKINELMER, INC.
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic Initiatives
7.3.4 FLUIDIGM CORPORATION
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic Initiatives
7.3.5 ILLUMINA, INC.
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 GE HEALTHCARE
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.6.4 Strategic Initiatives
7.3.7 BIO-RAD LABORATORIES, INC.
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.3 Strategic Initiatives
7.3.8 THERMO FISHER SCIENTIFIC, INC.
7.3.8.1 COMPANY OVERVIEW
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic Initiatives
7.3.9 LI-COR, INC.
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic Initiatives
7.3.10 MOLECULAR DEVICES, LLC
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic Initiatives
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List of Abbreviations
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 BIOCHIP INDUSTRY OUTLOOK
3.1 Market Segmentation
3.2 Market Size and Growth Prospects, 2021
3.3 Biochip Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increase in adoption of next-generation sequencing
3.3.1.2 Growing R&D in proteomics and genomics
3.3.1.3 Presence of an extensive drug-development pipeline
3.3.1.4 Increasing adoption of personalized medicine
3.3.1.5 Rapid technological advances in biochip technology
3.3.2 Market Restraint Analysis
3.3.2.1 High Cost Of Manufacturing
3.4 Key Opportunities Prioritized, 2021
3.5 Covid-19 Impact Analysis
3.6 Industry Analysis - Porter’s
3.7 Biochip Pestel Analysis
CHAPTER 4 BIOCHIP MARKET - SEGMENT ANALYSIS, BY TYPES, 2018 - 2030 (USD MILLION)
4.1 Global Biochip Market: Type Movement Analysis
4.2 DND Chips, By Application
4.2.1 DND Chips Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.2 Cancer Diagnosis And Treatment
4.2.2.1 Cancer Diagnosis And Treatment Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.3 Gene Expression
4.2.3.1 Gene Expression Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.4 Single Nucleotide Polymorphism (SNP) Genotyping
4.2.4.1 SNP Genotyping Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.5 Genomics
4.2.5.1 Genomics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.6 Drug Discovery
4.2.6.1 Drug Discovery Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.7 Agricultural Biotechnology
4.2.7.1 Agricultural Biotechnology Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.8 Others
4.2.8.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3 Lab-On-A-Chip, By Application
4.3.1 Lab-On-A-Chip Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.2 Clinical Diagnostics
4.3.2.1 Clinical Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.3 Genomics
4.3.3.1 Genomics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.4 In Vitro Diagnosis (IVD) & Point-Of-Care (POC)
4.3.4.1 IVD & POC Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.5 Proteomics
4.3.5.1 Proteomics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.6 Drug Discovery
4.3.6.1 Drug Discovery Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.7 Others
4.3.7.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4 Protein Chips, by Application
4.4.1 Protein Chips Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.2 Proteomics
4.4.2.1 Proteomics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.3 Expression Profiling
4.4.3.1 Expression Profiling Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.4 Diagnostics
4.4.4.1 Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.5 High Throughput Screening (HTS)
4.4.5.1 HTS Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.6 Drug Discovery
4.4.6.1 Drug Discovery Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.7 Others
4.4.7.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.5 Tissue Arrays
4.5.1 Tissue Arrays Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.6 Cell Arrays
4.6.1 Cell Arrays Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 5 BIOCHIP MARKET - SEGMENT ANALYSIS, BY END-USE, 2018 - 2030 (USD MILLION)
5.1 Global Biochip Market: End-Use Movement Analysis
5.2 Biotechnology And Pharmaceutical Companies
5.2.1 Biotechnology And Pharmaceutical Companies Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Hospitals And Diagnostics Centers
5.3.1 Hospitals And Diagnostics Centers Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Academic & Research Institutes
5.4.1 Academic & Research Institutes Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Others
5.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 BIOCHIP MARKET: - SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
6.1 Biochip Market: Regional Movement Analysis
6.2 North America
6.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.4 Spain
6.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.5 France
6.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.6 Italy
6.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2 Japan
6.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.3 China
6.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.4 India
6.4.4.1 India Market Estimates And Forecast, 2018 - 2030
6.4.5 South Korea
6.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030
6.4.6 Australia
6.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030
6.5 Latin America
6.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6 Middle East & Africa (MEA)
6.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6.1 South Africa
6.6.1.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6.2 Saudi Arabia
6.6.2.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6.3 UAE
6.6.3.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Public Companies
7.1.1 Company Market Position Analysis
7.1.2 Competitive Dashboard Analysis
7.1.3 Strategic Framework
7.2 Private Companies
7.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
7.2.2 Regional Network Map
7.3 Company Profiles
7.3.1 ABBOTT LABORATORIES
7.3.1.1 Company Overview
7.3.1.2 Alere, Inc.
7.3.1.3 Financial Performance
7.3.1.4 Product Benchmarking
7.3.1.5 Strategic Initiatives
7.3.2 AGILENT TECHNOLOGIES, INC.
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic Initiatives
7.3.3 PERKINELMER, INC.
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic Initiatives
7.3.4 FLUIDIGM CORPORATION
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic Initiatives
7.3.5 ILLUMINA, INC.
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 GE HEALTHCARE
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.6.4 Strategic Initiatives
7.3.7 BIO-RAD LABORATORIES, INC.
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.3 Strategic Initiatives
7.3.8 THERMO FISHER SCIENTIFIC, INC.
7.3.8.1 COMPANY OVERVIEW
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic Initiatives
7.3.9 LI-COR, INC.
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic Initiatives
7.3.10 MOLECULAR DEVICES, LLC
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic Initiatives
LIST OF TABLES
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Global Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 4 Global Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 5 Global Biochip Market, by Region, 2018 - 2030 (USD Million)
TABLE 6 North America Biochip Market, by Country, 2018 - 2030 (USD Million)
TABLE 7 North America Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 8 North America Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 9 U.S. Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 10 U.S. Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 11 Canada Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 12 Canada Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 13 Europe Biochip Market, by Country, 2018 - 2030 (USD Million)
TABLE 14 Europe Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 15 Europe Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 16 Germany Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 17 Germany Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 18 U.K. Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 19 U.K. Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 20 France Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 21 France Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 22 Italy Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 23 Italy Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 24 Spain Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 25 Spain Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 26 Asia Pacific Biochip Market, by Country, 2018 - 2030 (USD Million)
TABLE 27 Asia Pacific Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 28 Asia Pacific Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 29 China Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 30 China Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 31 Japan Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 32 Japan Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 33 India Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 34 India Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 35 South Korea Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 36 South Korea Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 37 Australia Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 38 Australia Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 39 Latin America Biochip Market, by Country, 2018 - 2030 (USD Million)
TABLE 40 Latin America Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 41 Latin America Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 42 Brazil Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 43 Brazil Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 44 Mexico Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 45 Mexico Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 46 Argentina Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 47 Argentina Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 48 Middle East & Africa Biochip Market, by Country, 2018 - 2030 (USD Million)
TABLE 49 Middle East & Africa Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 50 Middle East & Africa Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 51 South Africa Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 52 South Africa Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 53 Saudi Arabia Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 54 Saudi Arabia Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 55 UAE Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 56 UAE Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Global Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 4 Global Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 5 Global Biochip Market, by Region, 2018 - 2030 (USD Million)
TABLE 6 North America Biochip Market, by Country, 2018 - 2030 (USD Million)
TABLE 7 North America Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 8 North America Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 9 U.S. Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 10 U.S. Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 11 Canada Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 12 Canada Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 13 Europe Biochip Market, by Country, 2018 - 2030 (USD Million)
TABLE 14 Europe Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 15 Europe Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 16 Germany Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 17 Germany Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 18 U.K. Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 19 U.K. Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 20 France Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 21 France Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 22 Italy Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 23 Italy Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 24 Spain Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 25 Spain Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 26 Asia Pacific Biochip Market, by Country, 2018 - 2030 (USD Million)
TABLE 27 Asia Pacific Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 28 Asia Pacific Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 29 China Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 30 China Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 31 Japan Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 32 Japan Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 33 India Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 34 India Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 35 South Korea Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 36 South Korea Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 37 Australia Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 38 Australia Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 39 Latin America Biochip Market, by Country, 2018 - 2030 (USD Million)
TABLE 40 Latin America Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 41 Latin America Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 42 Brazil Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 43 Brazil Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 44 Mexico Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 45 Mexico Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 46 Argentina Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 47 Argentina Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 48 Middle East & Africa Biochip Market, by Country, 2018 - 2030 (USD Million)
TABLE 49 Middle East & Africa Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 50 Middle East & Africa Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 51 South Africa Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 52 South Africa Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 53 Saudi Arabia Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 54 Saudi Arabia Biochip Market, End-use, 2018 - 2030 (USD Million)
TABLE 55 UAE Biochip Market, by Type, 2018 - 2030 (USD Million)
TABLE 56 UAE Biochip Market, End-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Biochip Market Segmentation
FIG. 8 Market Snapshot, 2021
FIG. 9 Market Trends & Outlook
FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Market Penetration Vs Growth Prospect Mapping, 2021
FIG. 16 Global Biochip Market: Type Movement Analysis
FIG. 17 Global Biochip Market, for DNA Chips, 2018 - 2030 (USD Million)
FIG. 18 Global Biochip Market, for Protein Chips, 2018 - 2030 (USD Million)
FIG. 19 Global Biochip Market, for Lab-on-chip, 2018 - 2030 (USD Million)
FIG. 20 Global Biochip Market, for Tissue Arrays, 2018 - 2030 (USD Million)
FIG. 21 Global Biochip Market, for Cell Arrays 2018 - 2030 (USD Million)
FIG. 22 Global Biochip Market: End Use Movement Analysis
FIG. 23 Global Biochip Market, for Biotechnology and Pharmaceutical Companies, 2018 - 2030 (USD Million)
FIG. 24 Global Biochip Market, for Hospitals and Diagnostics Centers, 2018 - 2030 (USD Million)
FIG. 25 Global Biochip Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
FIG. 26 Global Biochip Market, for Others, 2018 - 2030 (USD Million)
FIG. 27 Regional Marketplace: Key Takeaways
FIG. 28 Regional Outlook, 2021 & 2030
FIG. 29 Global Biochip Market: Region Movement Analysis
FIG. 30 North America Biochip Market, 2018 - 2030 (USD Million)
FIG. 31 U.S. Biochip Market, 2018 - 2030 (USD Million)
FIG. 32 Canada Biochip Market, 2018 - 2030 (USD Million)
FIG. 33 Europe Biochip Market, 2018 - 2030 (USD Million)
FIG. 34 Germany Biochip Market, 2018 - 2030 (USD Million)
FIG. 35 U.K. Biochip Market, 2018 - 2030 (USD Million)
FIG. 36 France Biochip Market, 2018 - 2030 (USD Million)
FIG. 37 Italy Biochip Market, 2018 - 2030 (USD Million)
FIG. 38 Spain Biochip Market, 2018 - 2030 (USD Million)
FIG. 39 Asia Pacific Biochip Market, 2018 - 2030 (USD Million)
FIG. 40 Japan Biochip Market, 2018 - 2030 (USD Million)
FIG. 41 China Biochip Market, 2018 - 2030 (USD Million)
FIG. 42 India Biochip Market, 2018 - 2030 (USD Million)
FIG. 43 Australia Biochip Market, 2018 - 2030 (USD Million)
FIG. 44 South Korea Biochip Market, 2018 - 2030 (USD Million)
FIG. 45 Latin America Biochip Market, 2018 - 2030 (USD Million)
FIG. 46 Brazil Biochip Market, 2018 - 2030 (USD Million)
FIG. 47 Mexico Biochip Market, 2018 - 2030 (USD Million)
FIG. 48 Argentina Biochip Market, 2018 - 2030 (USD Million)
FIG. 49 Middle East and Africa Biochip Market, 2018 - 2030 (USD Million)
FIG. 50 South Africa Biochip Market, 2018 - 2030 (USD Million)
FIG. 51 Saudi Arabia Biochip Market, 2018 - 2030 (USD Million)
FIG. 52 UAE Biochip Market, 2018 - 2030 (USD Million)
FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Biochip Market Segmentation
FIG. 8 Market Snapshot, 2021
FIG. 9 Market Trends & Outlook
FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Market Penetration Vs Growth Prospect Mapping, 2021
FIG. 16 Global Biochip Market: Type Movement Analysis
FIG. 17 Global Biochip Market, for DNA Chips, 2018 - 2030 (USD Million)
FIG. 18 Global Biochip Market, for Protein Chips, 2018 - 2030 (USD Million)
FIG. 19 Global Biochip Market, for Lab-on-chip, 2018 - 2030 (USD Million)
FIG. 20 Global Biochip Market, for Tissue Arrays, 2018 - 2030 (USD Million)
FIG. 21 Global Biochip Market, for Cell Arrays 2018 - 2030 (USD Million)
FIG. 22 Global Biochip Market: End Use Movement Analysis
FIG. 23 Global Biochip Market, for Biotechnology and Pharmaceutical Companies, 2018 - 2030 (USD Million)
FIG. 24 Global Biochip Market, for Hospitals and Diagnostics Centers, 2018 - 2030 (USD Million)
FIG. 25 Global Biochip Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
FIG. 26 Global Biochip Market, for Others, 2018 - 2030 (USD Million)
FIG. 27 Regional Marketplace: Key Takeaways
FIG. 28 Regional Outlook, 2021 & 2030
FIG. 29 Global Biochip Market: Region Movement Analysis
FIG. 30 North America Biochip Market, 2018 - 2030 (USD Million)
FIG. 31 U.S. Biochip Market, 2018 - 2030 (USD Million)
FIG. 32 Canada Biochip Market, 2018 - 2030 (USD Million)
FIG. 33 Europe Biochip Market, 2018 - 2030 (USD Million)
FIG. 34 Germany Biochip Market, 2018 - 2030 (USD Million)
FIG. 35 U.K. Biochip Market, 2018 - 2030 (USD Million)
FIG. 36 France Biochip Market, 2018 - 2030 (USD Million)
FIG. 37 Italy Biochip Market, 2018 - 2030 (USD Million)
FIG. 38 Spain Biochip Market, 2018 - 2030 (USD Million)
FIG. 39 Asia Pacific Biochip Market, 2018 - 2030 (USD Million)
FIG. 40 Japan Biochip Market, 2018 - 2030 (USD Million)
FIG. 41 China Biochip Market, 2018 - 2030 (USD Million)
FIG. 42 India Biochip Market, 2018 - 2030 (USD Million)
FIG. 43 Australia Biochip Market, 2018 - 2030 (USD Million)
FIG. 44 South Korea Biochip Market, 2018 - 2030 (USD Million)
FIG. 45 Latin America Biochip Market, 2018 - 2030 (USD Million)
FIG. 46 Brazil Biochip Market, 2018 - 2030 (USD Million)
FIG. 47 Mexico Biochip Market, 2018 - 2030 (USD Million)
FIG. 48 Argentina Biochip Market, 2018 - 2030 (USD Million)
FIG. 49 Middle East and Africa Biochip Market, 2018 - 2030 (USD Million)
FIG. 50 South Africa Biochip Market, 2018 - 2030 (USD Million)
FIG. 51 Saudi Arabia Biochip Market, 2018 - 2030 (USD Million)
FIG. 52 UAE Biochip Market, 2018 - 2030 (USD Million)
